Objective evaluation for severity of atopic dermatitis by morphologic study of skin surface contours

被引:7
作者
Son, SW
Park, SY
Ha, SH
Park, GM
Kim, MG
Moon, JS
Yoo, DS
Oh, CH
机构
[1] Korea Univ, Sch Med, Dept Dermatol, Seoul 136701, South Korea
[2] Korea Univ, Sch Med, Res Inst Skin Image, Dept Dermatol, Seoul 136701, South Korea
[3] Korea Univ, Dept Elect & Informat Engn, Chungnam, South Korea
关键词
atopic dermatitis; bioengineering methods; stereoimage optical topometer;
D O I
10.1111/j.0909-725X.2005.00124.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/aims: Wide variation in outcome methodology can make the interpretation of patient outcomes confusing and the comparison of the results of different studies almost impossible. It is important to objectively measure and record the severity of atopic dermatitis (AD) for routine clinical practice and research. The aim of this study was to evaluate whether morphologic study of skin surface contours might be helpful to objectively quantify the severity of AD. Methods: Thirty atopic patients (12 females, 18 males) participated in this study. Moisturizer was applied twice daily for 2 weeks. Bioengineering methods such as D-Squame (R), corneometer, evaporimeter, and spectrophotometer were measured at the start of the study and after 1 week and 2 weeks. In addition, we assessed moisturizer effects after 3 h of moisturizer application.The stereoimage optical topometer (SOT) based on a new concept of stereoimage was applied for this study. We compared SOT, other bioengineering methods, and the severity scoring of atopic dermatitis (SCORAD) index. Results: After 3 h of application with moisturizer, the results measured by SOT, conventional optical profilometer (COP), D-Squame (R), and corneometer showed significant differences (P < 0.05). After 1 and 2 weeks, there were significant changes in the results measured by SOT, COP, D-Squame (R), corneometer, spectrophotometer, and SCORAD index. We observed a significant correlation between bioengineering methods and the SCORAD index (P < 0.05). Conclusion: These data indicate that morphologic study of skin surface contours are useful in evaluating of AD severity. If we would combine methods to evaluate the physiologic changes and those such as SOT to measure the morphological changes of skin surface, we could evaluate more objectively and quantitatively the severity of AD.
引用
收藏
页码:272 / 280
页数:9
相关论文
共 21 条
[1]   INDIVIDUAL AND INSTRUMENTAL VARIATIONS IN IRRITANT PATCH-TEST REACTIONS - CLINICAL-EVALUATION AND QUANTIFICATION BY BIOENGINEERING METHODS [J].
AGNER, T ;
SERUP, J .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1990, 15 (01) :29-33
[2]   Simple objective measurement of the cutaneous delayed-type hypersensitivity reaction to tuberculin using spectrophotometry [J].
Chambers, MA ;
Jahans, K ;
Whelan, A ;
Hughes, C ;
Sayers, R ;
Perkins, A ;
Hewinson, RG .
SKIN RESEARCH AND TECHNOLOGY, 2002, 8 (02) :89-93
[3]  
Chamlin SL, 2001, ARCH DERMATOL, V137, P1110
[4]   Outcome measures of disease severity in atopic eczema [J].
Charman, C ;
Williams, H .
ARCHIVES OF DERMATOLOGY, 2000, 136 (06) :763-769
[5]   Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring? [J].
Charman, C ;
Chambers, C ;
Williams, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (06) :932-941
[6]   International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies [J].
Ellis, C ;
Luger, T ;
Abeck, D ;
Allen, R ;
Graham-Brown, RAC ;
De Prost, Y ;
Eichenfield, LF ;
Ferrandiz, C ;
Giannetti, A ;
Hanifin, J ;
Koo, JYM ;
Leung, D ;
Lynde, C ;
Ring, J ;
Ruiz-Maldonado, R .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 :3-10
[7]  
HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
[8]  
JEMEC GBE, 1992, ACTA DERM-VENEREOL, P26
[9]   EVALUATION OF SKIN IRRITANCY OF SODIUM LAURYL SULFATE - A COMPARATIVE-STUDY BETWEEN THE REPLICA METHOD AND VISUAL EVALUATION [J].
KAWAI, K ;
NAKAGAWA, M ;
KAWAI, J ;
KAWAI, K .
CONTACT DERMATITIS, 1992, 27 (03) :174-181
[10]  
LINDE YW, 1992, ACTA DERM-VENEREOL, P9